NIH Funding · FY2024
Total Funding
$2.5M
Fiscal year 2024
Grants Awarded
8
Active NIH grants
National Rank
#3,501
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2.5M across 8 grants · National rank #3501.
Top grants by award amount
Jeffrey H. Price's NIH grant portfolio, ranked by award amount.
- 4R44MH135526-02R44Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)$1.1Maward amount
- 5R42HL158510-03R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$920.2Kaward amount
- 3R42HL158510-03S1R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$174Kaward amount
- 3R42HL158510-03S3R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$152.8Kaward amount
- 3R42HL158510-02S1R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$120.5Kaward amount
- 3R42HL158510-02S2R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$16.9Kaward amount
- 3R42HL158510-03S2R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$13.6Kaward amount
- 3R42HL158510-02S3R42Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes$9.5Kaward amount
Affiliation
Institutions that have administered grants for Jeffrey H. Price.
Affiliated with Vala Sciences, Inc. (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardVala Sciences, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3501
- 2024Entered Top 25% NationallyRanked #3501
Related investigators
Other NIH-funded PIs frequently associated with Jeffrey H. Price.
Explore further
Find collaborators for Jeffrey H. Price
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Vala Sciences, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →